ThermiGen LLC


Company Name:
ThermiGen LLC 
Sector:
Semiconductors & Semiconductor Capital Equipment 
Transaction Type:
Merger/Acquisition/Advisory 
Ticker Symbol:
- 
Deal Amount:
$77.5M
Transaction Date:
2/9/2016 
Transaction Summary:
ThermiGen LLC, a privately held medical aesthetics technology company and a leading developer and manufacturer of thermistor-regulated energy systems for plastic surgery and aesthetics dermatology applications, completed its previously announced sale to Almirall, S.A., a global pharmaceutical company based in Barcelona, Spain. In September 2015, Almirall acquired a minority stake in ThermiGen for $5 million representing 7.7% of the share capital of the company and paid $2.5 million in exchange of a call option right to acquire up to 100% of the company for an Enterprise Value of approximately $80 million. The call option to acquire 100% of the share capital of ThermiGen LLC was exercised by Almirall. Needham & Company acted as the exclusive financial advisor to ThermiGen LLC. 
Company Description:
ThermiGen LLC is a privately held medical aesthetics technology company and a leading developer and manufacturer of thermistor-regulated energy systems for plastic surgery and aesthetics dermatology applications. The Thermi flagship product is the ThermiRF®, Temperature Controlled Radio Frequency Generator System, which is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis, and to create lesions in nervous tissue. ThermiRF®, is an advanced technology using finely controlled thermal energy. It is a multi-use platform which uses proprietary hand pieces designed for specific medical applications and promotes increased patient safety and clinical effectiveness, while providing versatile solutions for physicians serving the aesthetic market. 
Investment Banking